AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups: Study
A new study conducted by Astra Zeneca was found to be 77% effective in preventing symptomatic coronavirus in high-risk people in a key trial that could expand the range of…
Share